Last reviewed · How we verify
Plasma NGAL level
At a glance
| Generic name | Plasma NGAL level |
|---|---|
| Sponsor | Centre Hospitalier Universitaire de Nīmes |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Plasma Neutrophil Gelatinase-Associated Lipocalin (pNGAL) Level in De-resuscitation With Furosemide Group and Control Group (NA)
- Is Permissive Hypotension Truly Harmless? Early Biomarker Evidence of Subclinical Kidney Injury in Rhinologic Surgery
- Development of an Innovative Clinico-biological Score for the Early Detection of Acute Renal Failure Associated With Cardiac Surgery.
- Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis
- Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women (NA)
- Intraoperative NGAL Level in Geriatric Patients Undergoing Laparotomy (NA)
- Comparison of Plasma Neutrophil Gelatinase - Associated Lipocalin (NGAL) Levels
- Plasma Aldosterone Levels and Atrial Fibrillation Reduction (ALDO-AF Study)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |